ICON has significant experience with cardiovascular imaging and biomarker generation from multiple imaging modalities across a spectrum of diseases.

  • 82

    Clinical trials
  • 15,269

  • 2,435


Our medical imaging professionals have experience in a broad range cardiovascular conditions including acute myocardial infarction, carotid vascular disease, cerebrovascular disease, congestive heart failure, drug-induced cardiotoxicity, great vessel aneurysm, myocardial ischemia, pulmonary arterial hypertension, non ischemic cardiomyopathies and peripheral vascular disease.

To support cardiovascular clinical trials, ICON has significant experience in all cardiovascular indications  imaging modalities including Echo, Angiography, SPECT, PET, CT, MRI, and any ECG gating requirements that support these applications. We have experience in both adult and pediatric populations across modalities. Our cardiovascular experience spans phases 1-3 of drug development, as well as in device testing.

We also deliver a robust mechanism for quality control, query resolution and independent reads. Highly trained and experienced medical imaging experts will provide support throughout the study – enabling improved clinical trial decision making, increased efficiency and reduced trial cost.

Delivering benefits to your cardiovascular trial:

– In-house board-certified cardiologist, nuclear medicine physician and radiologists

– In-house cardiac trained medical imaging scientists, board certified MRI physicist

– Certified imaging specialists with significant processing experience in CT, MR, vascular ultrasound, angiography, SPECT, PET and Echo

– Global network of cardiovascular imaging trained cardiologists and radiologists for both remote and monitored reads in all modalities

– Biomedical engineers

– Biostatistician

– Data management team

– Medical writers